This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This study investigated the impact of short-term exposure to acid sulphate soil leachate on the biochemical condition of the Pacific Oyster Crassostrea gigas. Oysters were exposed to artificially acidified seawater, aluminium and iron treatments for a period of six hours and assessed for changes in mantle glycogen, mantle protein and haemolymph protein between treatments.

An additional challenge using Vibrio harveyi extracellular products was conducted to reduce oyster condition and make them more vulnerable to impacts of acidified treatments. Despite depressed mantle protein levels, no significant differences in biochemical condition were found between control treatments and acidified water treatments indicating that short periods of exposure to acid leachate in the field would be unlikely to have significant impacts on general oyster condition.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

This project was designed to assist the Australian Seafood CRC identify research gaps and opportunities and ultimately provide the necessary background information and rationale for a potential supplementary bid to DIISR for funding of a new program of health related research.

The Food Standards Australia New Zealand (FSANZ) website and websites for the Japanese Ministry of Health, Labour, and Welfare and the US Food and Drug Administration were the major sources of information regarding health claims for Australia, Japan and the US. Japan and the US were included in this report as they are two key export markets for the Australian Seafood industry. Examples of seafoods, using specific seafoods of interest to the Seafood CRC were modeled for nutrition content and general level health claims. A brief review of the potential mechanisms of some of the observed health effects of fish and omega-3 fatty acids was undertaken.

The research described in this report found that one of the important mechanisms for the observed widespread effect of seafoods on a range of health outcomes (such as coronary heart disease, cancer, arthritis, dementia) is the dampening of the inflammatory response by the 2 key bioactives in seafood, namely the long chain omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA). However there are other bioactives in fish worth exploring further. Several research gaps were identified as part of this project and these are outlined in the report.

Potential collaborators or partners beyond the current CRC members and affiliates were identified and have been included in the body of the report, as are some early suggestions for alternative funding and funding models.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.

The purpose of this grant was to undertake collaborative research into the lipid and polyunsaturated fatty acid (PUFA) metabolism of Southern Bluefin Tuna (SBT) using a SBT cell line that was recently produced. This project followed an international trend towards increasing fish oil replacement in feeds for farmed fish to improve the sustainability of the target industry.

Very little is known about dietary fish oil replacement in Bluefin tuna species so the purpose of this research was to obtain data which may be used to predict the impacts of fish oil replacement in future manufactured feeds for farmed SBT. Since it was logistically difficult and expensive to obtain such data from traditional feeding trials with SBT, the approach using the SBT cell lines offered a more rapid and cost-effective alternative.